Navigation Links
DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
Date:12/15/2008

EL SEGUNDO, Calif., Dec. 15 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), today announced that it is working with the U.S. Department of Health and Human Services, Office of Inspector General ("OIG") to respond to a subpoena request for documents issued in connection with the civil investigation by the Department of Justice and the U.S. Attorney's Office for the Northern District of Georgia previously reported in the Company's Quarterly Report on 10-Q for the period ended September 30, 2008. The subpoena was sent from the OIG's office in Atlanta, Georgia and was received by the Company on December 12, 2008. The subpoena applies to the Company and its subsidiaries and covers a time period from January 1, 2003 to the present. In response to the subpoena, DaVita will produce a wide range of documents relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlicit, and Epogen. The Company intends to meet with representatives of the government to discuss the scope of the subpoena and the production of responsive documents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

To the Company's knowledge, no proceedings have been initiated against the Company at this time, although the Company cannot predict whether or when proceedings might be initiated. The Company intends to cooperate with the government's investigation.

"DaVita has been involved in several investigations over the last 9 years, including some covering issues that are repeated in this subpoena. We respect the government's need to ensure the appropriateness of healthcare provider practices, especially during times when pharmaceutical issues involve significant expense for Medicare. We look forward to meeting with government representatives on this new investigation and once again demonstrating the strength of our clinical outcomes and the integrity and comprehensiveness of DaVita's Compliance programs," said LeAnne Zumwalt, spokesperson for DaVita.

DaVita is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita.com Receives eHealthcare Leadership Award
2. DaVita.com Launches Physician Website
3. Tour DaVita Raises More Than $400K for Kidney Disease Awareness
4. DaVita Abstracts Accepted into American Society of Nephrology Meeting
5. Modern Healthcare Names DaVita One of the Best Places to Work
6. DaVita 3rd Quarter 2008 Results
7. Spokesman at the United Nations Joins DaVita
8. Tour DaVita Rides to Improve Kidney Disease Education
9. DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
10. DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards
11. DaVita Renal Dietitians Conduct First-Ever EYE on CKD Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... American ... chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at ... held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and products recently hosted the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. ... a group of fitness professional through the 8 hour interactive course to qualify ...
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during ... Water Life Science® and international water advocate, was honored by Ashram, Inc. as the ... ancient Egypt who knelt on the banks of the Nile to fill their red ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite ... sales leadership and to further develop their rapidly expanding portfolio of customer and ... with a concentration in Marketing and an M.B.A. with concentration in management from ...
(Date:5/26/2016)... ... , ... May 2016 – Lips may be a central feature on our ... numbers of clients now ask about lip plumping and primping techniques and want tips ... Advanced Dermatology P.C. , The trend is a national one, with 2.4 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CHESTERFIELD, Va. , May 25, 2016 /PRNewswire/ ... next-generation sequencing test for wounds and infections. This ... ALL parasites, and select viruses. The test requires ... area. David G. Bostwick ... molecular testing to facilitate wound healing: "We are ...
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
(Date:5/24/2016)...   , Study met ... bowel cleansing and superiority in , ... of the ascending colon   ... Norgine B.V. today announced new positive data from the phase ... preparation) versus standard 2 litre PEG with ascorbate. The study met ...
Breaking Medicine Technology: